Sickle cell and thalassaemia (Record no. 75447)

MARC details
000 -LEADER
fixed length control field 01794cam a2200181 4500
001 - CONTROL NUMBER
control field NMDX6003
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120401t2012 xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780956584687
080 ## - UNIVERSAL DECIMAL CLASSIFICATION NUMBER
Universal Decimal Classification number WH 170 WOR
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Worthington, David
245 ## - TITLE STATEMENT
Title Sickle cell and thalassaemia
Remainder of title handbook for laboratories
250 ## - EDITION STATEMENT
Edition statement 3rd ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. London
Name of publisher, distributor, etc. NHS Sickle Cell & Thalassaemia Screening Programme
Date of publication, distribution, etc. 2012
500 ## - GENERAL NOTE
General note Monograph
500 ## - GENERAL NOTE
General note 70 p.; 30 cm.
520 ## - SUMMARY, ETC.
Summary, etc. <p class="MsoNormal" style="text-align:justify;mso-layout-grid-align:none;
text-autospace:none"><span style="font-size: 8pt;">This is the third edition of theLaboratory Handbook and updates the second edition which was published inSeptember 2009. It includes amendments and additions to the policies andguidance that have been made since then. In many cases this has simply meant ‘fine-tuning’some aspects where further clarification was required. In some cases policy hasbeen updated. Most of these updates have appeared on the screening programmewebsite and have been published in <em>Circulate</em>. Information for laboratories is regularly updated in the laboratoryupdate section of the screening website (sct.screening.nhs.uk/labupdates) and laboratoriesare encouraged to check this section frequently. It must be emphasised from thebeginning that the policies described relate to a screening programme andnot a diagnostic service. No screening programme can detect everyhaemoglobinopathy, i.e. have a diagnostic sensitivity of 100%, and therefore itis likely that a few cases will be missed. This must be borne in mind when counselingcouples about the effectiveness of screening.</span></p>
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://sct.screening.nhs.uk/getdata.php?id=10756">http://sct.screening.nhs.uk/getdata.php?id=10756</a>
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Date last seen Price effective from Koha item type
        Ferriman information and Library Service (North Middlesex) Ferriman information and Library Service (North Middlesex) Shelves 07/06/2022   WH 170 WOR 07/06/2022 07/06/2022 Book
London Health Libraries Koha Consortium privacy notice